Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Cohort study (n=205) found unfavourable prognostic factors for mortality include chemotherapy within 4 weeks of symptom onset (odds ratio [OR] 3.51 [95% CI 1.16–10.59]; p=0.026) and male sex (OR 3.86 [95% CI 1.57–9.50]; p=0.0033).


The Lancet Oncology